May 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology ~1 min.Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....
March 21, 2025Johnson & Johnson Neurovascular leader heads for the exit ~1 min.Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....
March 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals ~2 min.Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....
March 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy ~1 min.Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....
March 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader ~1 min.Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....
January 28, 2025Johnson & Johnson's 2024 Fourth-Quarter and Full-Year Earnings Report Revealed ~2 min.Johnson & Johnson (JNJ) has released its highly anticipated earnings report for the fourth quarter and full-year of 2024....
February 28, 2025Pfizer Inc. PFE Announces Groundbreaking Cancer Treatment: Here is What You Should Know ~2 min.Pfizer Inc. PFE has recently made a groundbreaking announcement in the field of cancer treatment, attracting significant attention from investors....
November 17, 2024GSK's Ojjaara Receives Health Canada Approval for Myelofibrosis in Anemia Patients ~1 min.GSK PLC, a leading pharmaceutical company, has received approval from Health Canada for its groundbreaking drug, Ojjaara, to be used in the treatment of myelofibrosis in anemia patients....
January 15, 2025JJ to buy psychiatric drug developer Intra-Cellular for 14.6B ~2 min.In a major move to bolster its presence in the mental health sector, pharmaceutical giant JNJ Johnson & Johnson has announced its acquisition of Intra-Cellular Therapies for a staggering $14.6 billion....
January 12, 2025Vertex Pharmaceuticals Incorporated Faces Setbacks in Clinical Trials ~1 min.Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares experienced a slide recently due to setbacks in its clinical trials....
